Clinical and preclinical studies of drugs

Our team has 10 years of experience in managing these projects from the moment of research planning and strategy selection to the formation of the final report and transition to the next phase. We interact with clinical centers that have successfully passed inspections and audits of Roszdravnadzor and international pharmaceutical companies.

Phase II studies are one of the main stages among pre-registration studies, as they allow one to prove one of the most important properties of any medical product - its effectiveness on target groups of patients.

We have all the necessary resources to conduct labor-intensive phase II studies and organize them from the stage of writing the protocol to the full assessment of the results obtained, followed by the formation of recommendations for preparation for further studies.

The company has extensive connections with clinical centers located throughout the Russian Federation, EAEU and CIS countries, and resources for organizing and conducting high-quality late-phase studies, including international ones, on all existing nosologies in a short time and with an optimal budget.

The presence of experienced project managers and monitors on staff, as well as the use of validated electronic data collection and processing systems, allows us to quickly and efficiently conduct research of any complexity in accordance with legal regulations.

Post-marketing (post-registration) studies play an important role in further studying the safety and effectiveness of medical products, allowing us to obtain significant information in order to optimize their use, as well as to prevent withdrawal or restriction of sales.

Assistance in organizing studies of this phase will be especially useful for manufacturers of drugs that have been on the market for a long time, to prove the rationality of their use, and therefore confirm the clinical validity of the use of drugs, which is the key to further successful circulation in the pharmaceutical market.